MedPath

Analysis of Changes in Medication Prescriptions After Hospitalization for 4 Disciplines: Gerontology, Diabetology, Cardiology and Rheumatology: Medical, Pharmaceutical and Economic Aspects

Conditions
Diabetes
Cardiac Disease
Rheumatic Diseases
Interventions
Other: collection of prescription data
Registration Number
NCT03371303
Lead Sponsor
Assistance Publique Hopitaux De Marseille
Brief Summary

The modifications of the medicinal treatments secondary to the hospitalizations have multiple reasons: reassessment of the previous treatment (conciliation), new therapeutic necessities, potential risk of iatrogeny or of drug interaction, restrictions of the therapeutic booklet, classification in reserve or hospital prescription ... These modifications are potentially generating extra costs for the Health Insurance and are monitored under the terms of the Contract of Good Use. The aims of this analysis are to define the medical-pharmaceutical rationale of the treatment changes imposed by hospitalization in a university-hospital center, their influence on the security of the medical treatment of patients and their financial implications for healthcare organizations

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
cardiologycollection of prescription data-
rheumatologycollection of prescription data-
geriatricscollection of prescription data-
diabetologycollection of prescription data-
Primary Outcome Measures
NameTimeMethod
entry orders before hospitalization15 months
exit orders after hospitalization15 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Assistance Publique Hôpitaux de Marseille

🇫🇷

Marseille, France

© Copyright 2025. All Rights Reserved by MedPath